cardiovascularКардиоваскулярная терапия и профилактикаCardiovascular Therapy and Prevention1728-88002619-0125«SILICEA-POLIGRAF» LLC10.15829/1728-8800-2019-6-136-141cardiovascular-2372Research ArticleОБЗОРЫREVIEWSМетоды оценки и возможности инструментальной диагностики субклинического атеросклероза коронарных артерийAssessment methods and possibilities of instrumental diagnosis of subclinical atherosclerosis of coronary arterieshttps://orcid.org/0000-0001-8963-5325ГавриловаН. Е.GavrilovaN. E.

Доктор медицинских наук, старший научный сотрудник, главный врач.

Москва.

Moscow.

NGavrilova@gnicpm.ruhttps://orcid.org/0000-0001-9991-1063ЖаткинаМ. В.ZhatkinaM. V.

Врач-кардиолог отделения рентгенхирургических методов диагностики и лечения, соискатель.

Москва.

Тел.: +7 (925) 437-80-54

Moscow.

MZhatkina@gnicpm.ruhttps://orcid.org/0000-0001-8665-9129МетельскаяВ. А.MetelskayaV. A.

Доктор биологических наук, профессор, ученый секретарь.

Москва.

Moscow.

VMetelskaya@gnicpm.ruhttps://orcid.org/0000-0002-5475-0048РуденкоБ. А.RudenkoB. A.

Доктор медицинских наук, профессор, ведущий научный сотрудник лаборатории рентгенэндоваскулярных методов диагностики и лечения.

Москва.

Moscow.

BRodenko@gnicpm.ruhttps://orcid.org/0000-0002-4453-8430ДрапкинаО. М.DrapkinaO. M.

Доктор медицинских наук, профессор, член-корреспондент РАН, директор.

Москва.

Moscow.

ODrapkina@gnicpm.ruНациональный медицинский исследовательский центр профилактической медицины Министерства здравоохранения Российской ФедерацииРоссияNational Medical Research Center for Preventive MedicineRussian Federation201915102019186136141Copyright © Гаврилова Н.Е., Жаткина М.В., Метельская В.А., Руденко Б.А., Драпкина О.М., 20192019Гаврилова Н.Е., Жаткина М.В., Метельская В.А., Руденко Б.А., Драпкина О.М.Gavrilova N.E., Zhatkina M.V., Metelskaya V.A., Rudenko B.A., Drapkina O.M.This work is licensed under a Creative Commons Attribution 4.0 License.https://cardiovascular.elpub.ru/jour/article/view/2372

Субклинический атеросклероз коронарных артерий — частая причина неблагоприятных сердечно-сосудистых событий: инфаркта миокарда, инсульта, внезапной сердечной смерти. В настоящее время существует большой арсенал методов диагностики коронарного атеросклероза. В статье представлены их основные характеристики, преимущества и недостатки, возможности использования в рутинной клинической практике.

Subclinical coronary arteriosclerosis is a common cause of adverse cardiovascular events: myocardial infarction, stroke, sudden cardiac death. Currently, there is a large arsenal of methods for diagnosing coronary atherosclerosis. The article presents its main characteristics, advantages and disadvantages, the possibility of use in routine clinical practice.

субклинический атеросклерозсердечно-сосудистый рискатеросклеротическая бляшкакоронарные артерииметоды диагностикиsubclinical atherosclerosiscardiovascular riskatherosclerotic plaquecoronary arteriesdiagnostic methodsReferencesHerrington W, Lacey B, Sherliker P, et al. Epidemiology of Atherosclerosis and the Potential to Reduce the Global Burden of Atherothrombotic Disease. Circ Res. 2016;118(4):535-46. doi:10.1161/CIRCRESAHA.115.307611.Herrington W, Lacey B, Sherliker P, et al. Epidemiology of Atherosclerosis and the Potential to Reduce the Global Burden of Atherothrombotic Disease. Circ Res. 2016;118(4):535-46. doi:10.1161/CIRCRESAHA.115.307611.Pandya A, Gaziano T, Weinstein M, Cutler D. More americans living longer with cardiovascular disease will increase costs while lowering quality of life. Health Affair. 2013;32(10):1706-14. doi:10.1377/hlthaff.2013.0449.Pandya A, Gaziano T, Weinstein M, Cutler D. More americans living longer with cardiovascular disease will increase costs while lowering quality of life. Health Affair. 2013;32(10):1706-14. doi:10.1377/hlthaff.2013.0449.Heris A, Lacer B, Sherlir A, et al. Prevalence of coronary heart disease. Circ Res. 2016;117(5):520-30. doi:10.1161/CIRCRESAHA.Heris A, Lacer B, Sherlir A, et al. Prevalence of coronary heart disease. Circ Res. 2016;117(5):520-30. doi:10.1161/CIRCRESAHA.Frostegard J. Immunity, atherosclerosis and cardiovascular disease. BMC Med. 2013;11(1):117 doi:10.1186/1741-7015-11-117.Frostegard J. Immunity, atherosclerosis and cardiovascular disease. BMC Med. 2013;11(1):117 doi:10.1186/1741-7015-11-117.Falk E, Shah P, Fuster V. Coronary plaque disruption. Circulation. 1995;(92):657-71. doi:10.1161/01.cir.92.3.657.Falk E, Shah P, Fuster V. Coronary plaque disruption. Circulation. 1995;(92):657-71. doi:10.1161/01.cir.92.3.657.Goel S, Miller A, Agarwal C, et al. Imaging Modalities to Identity Inflammation in anAtherosclerotic Plaque. Radiol Res Pract. 2015;(14):21-4. doi:10.1155/2015/410967.Goel S, Miller A, Agarwal C, et al. Imaging Modalities to Identity Inflammation in anAtherosclerotic Plaque. Radiol Res Pract. 2015;(14):21-4. doi:10.1155/2015/410967.Viera AJ, Sheridan SL. Global risk of coronary heart disease: assessment and application. Am Fam Physician. 2010;82(3):265-74.Viera AJ, Sheridan SL. Global risk of coronary heart disease: assessment and application. Am Fam Physician. 2010;82(3):265-74.Little WC, Applegate RJ. Can arteriography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease? Circulation. 1988;(78):1157-66.Little WC, Applegate RJ. Can arteriography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease? Circulation. 1988;(78):1157-66.Simon A, Chironi G, Levenson J. Performance of subclinical arterial disease detection as a screening test for coronary heart disease. Hypertension. 2006;(3):392-6.Simon A, Chironi G, Levenson J. Performance of subclinical arterial disease detection as a screening test for coronary heart disease. Hypertension. 2006;(3):392-6.Blankenhorn DH, Curry PJ The accuracy of arteriography and ultrasoundimaging for atherosclerosis measurement: a review. Arch Pathol Lab Med. 1982;106:483-9.Blankenhorn DH, Curry PJ The accuracy of arteriography and ultrasoundimaging for atherosclerosis measurement: a review. Arch Pathol Lab Med. 1982;106:483-9.Гаврилова Н. Е., Метельская В. А., Перова Н. В. и др. Выбор метода количественной оценки поражения коронарных артерий на основе сравнительного анализа ангиографических шкал. Российский кардиологический журнал. 2014;6:24-29. doi:10.15829/1560-4071-2014-4-108-112.Gavrilova NE, Metelskaya VA, Perova NV, et al. The choice of a method of quantitative assessment of defeat of coronary arteries on the basis of the comparative analysis of angiographic scales. Russian Journal of Cardiology. 2014;6:24-9. (In Russ.)Roberts WC, Jones AA. Quantitation of coronary arterial narrowing at necropsy in sudden coronary death: analysis of 31 patients and comparison with 25 control subjects. Am J Cardiol. 1979;44:39-45.Roberts WC, Jones AA. Quantitation of coronary arterial narrowing at necropsy in sudden coronary death: analysis of 31 patients and comparison with 25 control subjects. Am J Cardiol. 1979;44:39-45.Fleg J, Stone G, Fayad Z, et al. Detection of High-Risk Atherosclerotic Plaque. Report of the NHLBI Working Group on Current Status and Future Directions. 2012;5(9):941-55. doi:10.1016/j.jcmg.2012.07.007.Fleg J, Stone G, Fayad Z, et al. Detection of High-Risk Atherosclerotic Plaque. Report of the NHLBI Working Group on Current Status and Future Directions. 2012;5(9):941-55. doi:10.1016/j.jcmg.2012.07.007.Rioufol G, Finet G, Ginon I, et al. Multiple atherosclerotic plaque rupture in acute coronary syndrome: a three-vessel intravascular ultrasound study. Circulation. 2002;106:804-8. doi:10.1161/01.cir.0000025609.13806.31.Rioufol G, Finet G, Ginon I, et al. Multiple atherosclerotic plaque rupture in acute coronary syndrome: a three-vessel intravascular ultrasound study. Circulation. 2002;106:804-8. doi:10.1161/01.cir.0000025609.13806.31.Кузнецов В.А., Ярославская Е. И. Коронарный атеросклероз: данные Тюменского регистра. Тюмень: ООО “Издательско-полиграфический центр “Экспресс”, 2018:204 с. ISBN 978-5-86093-417-9.Kuznetsov VA, Yaroslavskaya EI. Koronarny atherosclerosis: data of the Tyumen Register. Tyumen: Publishing and Printing Center Express, 2018:204. (In Russ.)Stone NJ, Robinson JG, Lichtenstein AH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults. Circulation. 2014;129:S1.Stone NJ, Robinson JG, Lichtenstein AH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults. Circulation. 2014;129:S1.Muntner P, Colantonio LD, Cushman M, et al. Validation of the atherosclerotic cardiovascular disease pooled cohort risk equations. JAMA. 2014;311:1406-15. doi:10.1001/jama.2014.2630.Muntner P, Colantonio LD, Cushman M, et al. Validation of the atherosclerotic cardiovascular disease pooled cohort risk equations. JAMA. 2014;311:1406-15. doi:10.1001/jama.2014.2630.QRISK2 risk calculator https://qrisk.org (2016). Дата обращения: 23.04.2019.QRISK2 risk calculator https://qrisk.org (2016). Дата обращения: 23.04.2019.Conroy RM, Pyorala KA, Fitzgerald AP, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur. Heart. J. 2003;24:987-1003.Conroy RM, Pyorala KA, Fitzgerald AP, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur. Heart. J. 2003;24:987-1003.Kannel WB, McGee D, Gordon T. A general cardiovascular risk profile: the Framingham Study. Am J Cardiol 1976;38:46-51.Kannel WB, McGee D, Gordon T. A general cardiovascular risk profile: the Framingham Study. Am J Cardiol 1976;38:46-51.Schnabel R. B., Sullivan L. M., Levy D. et al. Development of a Risk Score for Atrial Fibrillation in the Community; The Framingham Heart Study Lancet 2009;373(9665):739-45.Schnabel R. B., Sullivan L. M., Levy D. et al. Development of a Risk Score for Atrial Fibrillation in the Community; The Framingham Heart Study Lancet 2009;373(9665):739-45.Anderson TJ, Gregoire J, Pearson GJ, et al. Canadian Cardiovascular Society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in the adult. Can J Cardiol. 2016;32(11):1263-82. doi:10.1177/1715163517713031.Anderson TJ, Gregoire J, Pearson GJ, et al. Canadian Cardiovascular Society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in the adult. Can J Cardiol. 2016;32(11):1263-82. doi:10.1177/1715163517713031.Anderson NV. Intraarterial anayaapal pografiy. J Intern Med. 2012;12(2):23-6. doi:1036.1111/j.1365-2796.2011.02493.Anderson NV. Intraarterial anayaapal pografiy. J Intern Med. 2012;12(2):23-6. doi:1036.1111/j.1365-2796.2011.02493.Чуян Е.Н., Ананченко М. Н., Трибрат Н. С. Современные биофизические методы исследования процессов микроциркуляции. Ученые записки Таврического национального университета имени В. И. Вернадского. 2009;1:99-112.Chuyan EN, Ananchenko MN, Tribrat NS. Modern biophysical methods of research of microcirculation processes. Scientists of notes of Tavrichesky National University named after V. I . Vernadsky. 2009;1:99-112. (In Russ.)Erlinge D. Near-infrared spectroscopy for intracoronarydetection of lipid-rich plaques to understand atherosclerotic plaquebiology in man and guide clinical therapy. J Intern Med. 2015;278(2):110-25. doi:10.1111/joim.12381Erlinge D. Near-infrared spectroscopy for intracoronarydetection of lipid-rich plaques to understand atherosclerotic plaquebiology in man and guide clinical therapy. J Intern Med. 2015;278(2):110-25. doi:10.1111/joim.12381Al-Qaisi M, Nott DM, King DH, Kaddoura S. Ankle brachial pressure index (ABPI): An update for practitioners. Vasc Health Risk Manag. 2009;5:833-41. doi:10.2147/VHRM.S6759.Al-Qaisi M, Nott DM, King DH, Kaddoura S. Ankle brachial pressure index (ABPI): An update for practitioners. Vasc Health Risk Manag. 2009;5:833-41. doi:10.2147/VHRM.S6759.Doobay AV, Anand SS. Sensitivity and specificity of the ankle-brachial index to predict future cardiovascular outcomes: a systematic review. Arterioscler Thromb Vasc Biol. 2005;25(7):1463-9. doi:10.1161/01.ATV.0000168911.78624.b7.Doobay AV, Anand SS. Sensitivity and specificity of the ankle-brachial index to predict future cardiovascular outcomes: a systematic review. Arterioscler Thromb Vasc Biol. 2005;25(7):1463-9. doi:10.1161/01.ATV.0000168911.78624.b7.Khan TH, Farooqui FA, Niazi K. Critical review of the ankle brachial index. Curr Cardiol Rev. 2008;4(2):101-6. doi:10.2174/157340308784245810.Khan TH, Farooqui FA, Niazi K. Critical review of the ankle brachial index. Curr Cardiol Rev. 2008;4(2):101-6. doi:10.2174/157340308784245810.McDermott MM, Liu K, Criqui MH, et al. Ankle-brachial index and subclinical cardiac and carotid disease: the multi-ethnic study of atherosclerosis. Am J Epidemiol. 2005;162(1):33-41. doi:10.1093/aje/kwi167.McDermott MM, Liu K, Criqui MH, et al. Ankle-brachial index and subclinical cardiac and carotid disease: the multi-ethnic study of atherosclerosis. Am J Epidemiol. 2005;162(1):33-41. doi:10.1093/aje/kwi167.Papamichael CM, Lekakis JP, Stamatelopoulos KS, et al. Ankle-brachial index as a predictor of the extent of coronary atherosclerosis and cardiovascular events in patients with coronary artery disease. Am J Cardiol. 2000;86(6):615-8. doi:10.1016/S0002-9149(00)01038-9.Papamichael CM, Lekakis JP, Stamatelopoulos KS, et al. Ankle-brachial index as a predictor of the extent of coronary atherosclerosis and cardiovascular events in patients with coronary artery disease. Am J Cardiol. 2000;86(6):615-8. doi:10.1016/S0002-9149(00)01038-9.Kajikawa M, Maruhashi T, Iwamoto Y, et al. Borderline Ankle-Brachial Index Value of 0.91-0.99 Is Associated With Endothelial Dysfunction. CircJ. 2014;78(7):1740-5. doi:10.1253/circj.CJ-14-0165.Kajikawa M, Maruhashi T, Iwamoto Y, et al. Borderline Ankle-Brachial Index Value of 0.91-0.99 Is Associated With Endothelial Dysfunction. CircJ. 2014;78(7):1740-5. doi:10.1253/circj.CJ-14-0165.Tanaka S, Kaneko H, Kano H, et al. The predictive value of the borderline ankle-brachial index for long-term clinical outcomes: An observational cohort study. Atherosclerosis. 2016;250:69-76. doi:10.1016/j.atherosclerosis.2016.05.014.Tanaka S, Kaneko H, Kano H, et al. The predictive value of the borderline ankle-brachial index for long-term clinical outcomes: An observational cohort study. Atherosclerosis. 2016;250:69-76. doi:10.1016/j.atherosclerosis.2016.05.014.Centers for Disease Control and Prevention (CDC) NCfHSN. National Health and Nutrition Examination Survey Datа (NHANES). https://wwwn.cdc.gov/nchs/nhanes/analyticguidelines.aspx.Accessed (Dec 2017). Дата обращения: 23.04.2019.Centers for Disease Control and Prevention (CDC) NCfHSN. National Health and Nutrition Examination Survey Datа (NHANES). https://wwwn.cdc.gov/nchs/nhanes/analyticguidelines.aspx.Accessed (Dec 2017). Дата обращения: 23.04.2019.Васильев А. Ю., Алексахина Т. Ю. Применение спиральной компьютерной томографии в качестве первичного скрининга атеросклеротического кальциноза коронарных артерий. Медицинская практика. 2004;1:40-2.Vasilyev AY, Aleksakhina TY. Use of a spiral computer tomography as primary screening of atherosclerotic calcification of coronary arteries. Medical practice. 2004;1:40-2. (In Russ.)Schader S, Kopp A, Kuettner F, et al. Influence of heart rate on vessel visibility in noninvave coronary angiography using new miltislice computed tomography. Experiencein 94 patients. Clinicalimaging. 2002;26:106-11.Schader S, Kopp A, Kuettner F, et al. Influence of heart rate on vessel visibility in noninvave coronary angiography using new miltislice computed tomography. Experiencein 94 patients. Clinicalimaging. 2002;26:106-11.Синицын В. Е., Терновой С. К. Новая роль мультиспиральной компьтерной томографии в диагностике болезней сердца и сосудов. Терапевтический архив. 2007;(4):10-11.Sinitsin VE, Ternovoy SK. The role of multispiral compter tomography in the diagnosis of heart and vascular diseases. Therapeutic Archive. 2007;(4):10-11. (In Russ)Budoff MJ, Shaw LJ, Liu ST. Long-term prognosis associated with coronary calcification: observations from a registry of 25,253 patients. JACC. 2007;49(18):1860-5.Budoff MJ, Shaw LJ, Liu ST. Long-term prognosis associated with coronary calcification: observations from a registry of 25,253 patients. JACC. 2007;49(18):1860-5.Geluk CA, Dikkers R, Perik PJ. Measurement of coronary calcium scores by electron beam computed tomography or exercise testing as initial diagnostic tool in low-risk patients with suspected coronary artery disease. Eur. Radiol. 2008;8(2):244-52. doi:10.1007/s00330-007-0755-2.Geluk CA, Dikkers R, Perik PJ. Measurement of coronary calcium scores by electron beam computed tomography or exercise testing as initial diagnostic tool in low-risk patients with suspected coronary artery disease. Eur. Radiol. 2008;8(2):244-52. doi:10.1007/s00330-007-0755-2.Yuan C, Zhang SX, Polissar NL et al. Identification of fibrous cap rupture with magnetic resonance imaging is highly associated with recent transient ischemic attack or stroke. Circulation. 2002;105:181-5. doi:10.1161/hc0202.102121.Yuan C, Zhang SX, Polissar NL et al. Identification of fibrous cap rupture with magnetic resonance imaging is highly associated with recent transient ischemic attack or stroke. Circulation. 2002;105:181-5. doi:10.1161/hc0202.102121.Yuan C, Mitsumori LM, Beach KW, Maravilla KR. Carotid atherosclerotic plaque: noninvasive MR characterization and identification of vulnerable lesions. Radiology. 2001;(221):285-99. doi:10.1148/radiol.2212001612.Yuan C, Mitsumori LM, Beach KW, Maravilla KR. Carotid atherosclerotic plaque: noninvasive MR characterization and identification of vulnerable lesions. Radiology. 2001;(221):285-99. doi:10.1148/radiol.2212001612.Ripa RS, Kjaer A. Imaging atherosclerosis with hybrid positron emission tomography/magnetic resonance imaging. Biomed Res Int. 2015;2015:914516. doi:10.1155/2015/914516.Ripa RS, Kjaer A. Imaging atherosclerosis with hybrid positron emission tomography/magnetic resonance imaging. Biomed Res Int. 2015;2015:914516. doi:10.1155/2015/914516.Regar E, Serruys PW. Ten years after introduction of intravascular ultrasound in the catheterization laboratory: tool or toy? 2002;91:89-97.Regar E, Serruys PW. Ten years after introduction of intravascular ultrasound in the catheterization laboratory: tool or toy? 2002;91:89-97.Groves EM, Seto AH, Kern MJ. Invasive Testing for Coronary Artery Disease: FFR, IVUS, OCT, NIRS. Heart Fail Clin. 2016;12(1):83-95. doi:10.1016/j.ccl.2014.04.005.Groves EM, Seto AH, Kern MJ. Invasive Testing for Coronary Artery Disease: FFR, IVUS, OCT, NIRS. Heart Fail Clin. 2016;12(1):83-95. doi:10.1016/j.ccl.2014.04.005.Frimerman A, Miller HI, Siegel RJ, et al. Intravascular ultrasound imaging of myocardial_infarction_related arteries after percutaneous transluminal coronary angioplasty reveals significant plsgue burden and compensatory enlargement. Inter J Cardivasc Intervent. 1999;2:101-7.Frimerman A, Miller HI, Siegel RJ, et al. Intravascular ultrasound imaging of myocardial_infarction_related arteries after percutaneous transluminal coronary angioplasty reveals significant plsgue burden and compensatory enlargement. Inter J Cardivasc Intervent. 1999;2:101-7.Mintz GS, Nissen SE, Anderson WD, et al. American College of Cardiology Clinical Expert Consensus Document on Standards for Acquisition, Measurement and Reporting of Intravascular Ultrasound Studies (IVUS). A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. JACC. 2001;37:1478-92.Mintz GS, Nissen SE, Anderson WD, et al. American College of Cardiology Clinical Expert Consensus Document on Standards for Acquisition, Measurement and Reporting of Intravascular Ultrasound Studies (IVUS). A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. JACC. 2001;37:1478-92.Schaar JA, Korte CL, Mastik F, et al. Characterizing vulnerable plaque features with intravascular elastography. Circulation. 2003;108:2636-41.Schaar JA, Korte CL, Mastik F, et al. Characterizing vulnerable plaque features with intravascular elastography. Circulation. 2003;108:2636-41.Taniwaki M. Long-term safety and feasibility of three-vessel multimodality intravascular imaging in patients with ST-elevation myocardial infarction: the IBIS-4 (integrated biomarker and imaging study) substudy. Internat J Cardiovasc Imaging. 2015;31(5):915-26. doi:10.1007/s10554-015-0631-0.Taniwaki M. Long-term safety and feasibility of three-vessel multimodality intravascular imaging in patients with ST-elevation myocardial infarction: the IBIS-4 (integrated biomarker and imaging study) substudy. Internat J Cardiovasc Imaging. 2015;31(5):915-26. doi:10.1007/s10554-015-0631-0.

The authors declare that there are no conflicts of interest present.